In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 28th, 2005 | 25 | No |
11.beta.-Hydroxy-6.alpha.-methylpregn-4-ene-3,20-dione
11.beta.-Hydroxy-6.alpha.-methylprogesterone
11beta-Hydroxy-6alpha-methyl-4-pregnene-3,20-dione
11beta-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione
11beta-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione; 2668-66-8; C14643; Medrysone
2668-66-8; D02289; HMS (TN); Medrysone (USAN)
2668-66-8; Medrysone; Prestwick_89
6.alpha.-Methyl-11.beta.-hydroxyprogesterone
6A-methyl-11B-hydroxyprogesterone
6ALPHA-METHYL-11BETA-HYDROXYPROGESTERONE; CPD000058693; Medrysone; SAM002564258
6ALPHA-METHYL-11BETA-HYDROXYPROGESTERONE; CPD000058693; SAM002564258
Pregn-4-ene-3,20-dione, 11-hydroxy-6-methyl-, (6.alpha.,11.beta.)-
Pregn-4-ene-3,20-dione, 11.beta.-hydroxy-6.alpha.-methyl-
Progesterone, 11.beta.-hydroxy-6.alpha.-methyl-
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.37 | 9.07 | -10.95 | 1 | 3 | 0 | 54 | 344.495 | 1 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 3.37e-02 g/l | DrugBank-approved |
Therapy | glucocorticoid | SMDC Pharmakon |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : M-1163; NCC_SUPPLIER_SAMPLE_COMMENTS : WHITE POWDER, YELLOW CAST | NIH Clinical Collection via PubChem |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: M-1163; SUPPLIER_COMMENTS: WHITE POWDER, YELLOW CAST | NIH Clinical Collection via PubChem |